Dual GLP-1/GIP receptor agonists (molecules engineered to simultaneously activate GLP-1R and GIPR) represent a pharmacological leap beyond classical incretin-based therapies
Toss gently and serve immediately
Any platform implying that compounded GLP-1 treatment is equivalent to a branded FDA-approved product is misrepresenting the regulatory status
Tirzepatide is very similar to Semaglutide
Yet, in many countries the devices being used to deliver GLP-1s are the same for both the weight loss and T2D populations and, in many cases, were originally designed for delivering insulin, such as Novo Nordisks FlexTouch pen (Wegovy, semaglutide) or Eli Lillys KwikPen (Mounjaro, tirzepatide) outside the US
This advanced formula replenishes NAD+, repairs cellular damage, and protects against oxidative stress while enhancing energy, focus, and athletic performance